Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy

The treatment of patients with chronic hepatitis C virus (HCV) infection has changed tremendously over the past 2 years, with an increasing variety of all-oral direct-acting antiviral (DAA) treatment regimens available for different HCV genotypes and distinct clinical settings. These treatments have...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbanowicz, Arkadiusz, Zagożdżon, Radosław, Ciszek, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420452/
https://www.ncbi.nlm.nih.gov/pubmed/30443787
http://dx.doi.org/10.1007/s00005-018-0532-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420452/
https://www.ncbi.nlm.nih.gov/pubmed/30443787
http://dx.doi.org/10.1007/s00005-018-0532-8

Ejemplares similares